ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print August 9, 2006, 10.1183/09031936.06.00043506
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/6/1186    most recent
09031936.06.00043506v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thunnissen, F. B.
Right arrow Articles by Flieder, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thunnissen, F. B.
Right arrow Articles by Flieder, D. B.
Eur Respir J 2006; 28:1186-1189
Copyright ©ERS Journals Ltd 2006

EU–USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer

F. B. Thunnissen1, K. M. Kerr2, E. Brambilla3, C. E. Comin4, W. A. Franklin5, B. Guldhammerskov6, W. H. Westra7 and D. B. Flieder8

1 Dept of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, 2 Dept of Pathology, Aberdeen University School of Medicine, Aberdeen Royal Infirmary, Aberdeen, UK, 3 Dept of Pathology, INSERM U578, Grenoble, France, 4 Dept of Human Pathology and Oncology, University of Florence, Florence, Italy, 6 Dept of Pathology, KAS Herlev, div. Gentofte, Hellerup, Denmark., 5 Dept of Pathology, University of Colorado Health Science Centre, Aurora, CO 7 Dept of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, and 8 Fox Chase Cancer Centre, Philadelphia, PA, USA.

CORRESPONDENCE: F. B. Thunnissen, Dept of Pathology, VU Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Fax: 31 204444586. E-mail: e.thunnissen{at}vumc.nl

Keywords: Diagnosis, lung cancer, panel, pathology, screening

Received: March 29, 2006
Accepted July 31, 2006

Randomised controlled trials for lung cancer screening using high-resolution computed tomography are now underway. In order to allow effective future comparison of the different trials, as well as strengthening conclusions based upon the analysis of larger data sets, uniformity and consistency of pathology diagnosis are essential. The aim of the present study was to determine the effectiveness of the learning process in this difficult area of diagnostic pathology.

Eight pathologists received two CD-ROMs, each with digital images of 30 cases. After diagnosing the first series, selected background reading was provided. Kappa ({kappa}) scores were calculated for each pathologist and category, and were compared to the consensus score.

The readings of the first series showed a moderate agreement {kappa} score: mean±SD for category numbers 8 (all eight categories) and 2 were 0.53±0.05 and 0.65±0.04, respectively. The {kappa} 2 score distinguished between categories denoting benign and malignant lesions. The second series resulted in a good agreement {kappa} score: 0.65±0.06 for category number 8 and 0.81±0.02 for category number 2.

In conclusion, this study demonstrates that screen-detected cases pose particular problems for pathologists and that a trained pathology panel serving randomised controlled trials is likely to lead to more consistent and accurate tissue diagnosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.